SPRO icon

Spero Therapeutics

89 hedge funds and large institutions have $370M invested in Spero Therapeutics in 2020 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 34 increasing their positions, 23 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

14% more funds holding

Funds holding: 7889 (+11)

5.53% more ownership

Funds ownership: 64.67%70.19% (+5.5%)

26% less call options, than puts

Call options by funds: $1.5M | Put options by funds: $2.04M

Holders
89
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.5M
Puts
$2.04M
Net Calls
Net Calls Change

Top Buyers

1 +$17.4M
2 +$12.7M
3 +$5.15M
4
Morgan Stanley
Morgan Stanley
New York
+$4.81M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$3.91M

Top Sellers

1 -$11M
2 -$6.87M
3 -$4.31M
4
AIC
AWM Investment Company
New York
-$2.44M
5
AG
Artal Group
Luxembourg
-$1.94M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$1.14M
27
$1.13M
28
$1.01M
29
$1M
30
$962K
31
$950K
32
$841K
33
$811K
34
$807K
35
$667K
36
$633K
37
$600K
38
$593K
39
$582K
40
$494K
41
$458K
42
$432K
43
$401K
44
$375K
45
$373K
46
$339K
47
$297K
48
$294K
49
$278K
50
$268K